The Transaxillary Route As a Second Access Option in TAVI Procedures: Experience of a Single Centre

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Jul 27

PMID 35886501

Authors

Saverio Muscoli

Valeria Cammalleri

Michela Bonanni

Francesca Romana Prandi

Angela Sanseviero

Gianluca Massaro

Marco Di Luozzo

Marcello Chiocchi

Andrea Ascoli Marchetti

Arnaldo Ippoliti

Alessia Zingaro

Gian Paolo Ussia

Francesco Romeo

Pasquale De Vico

Affiliations

Soon will be listed here.

Abstract

The aim of our study was to determine the feasibility and efficacy of transaxillary (TAX) TAVI in patients not eligible for the transfemoral route. This is a retrospective study of a single center. We analysed 262 patients treated with TAVI. In 17 patients (6.5%), the procedure was performed with the TAX approach. Procedural and hospital data, 30-day safety, and clinical efficacy were assessed and compared between the transfemoral and TAX groups. In the TAX groups, we found a higher prevalence of men ( = 0.001), smokers ( = 0.033), and previous strokes ( = 0.02). The EUROSCORE II was higher in the TAX group ( = 0.014). The success rate of the device was 100%. TAX was associated with a longer procedure time ( = 0.001) and shorter median device time ( = 0.034) in minutes. Patients treated with TAX had a longer hospital stay ( = 0.005) and higher overall bleeding rate ( = 0.001). Peripheral neurological complications were more frequent with TAX ( = 0.001), which almost completely resolved by 30 days. TAX TAVI is safe and effective and should be considered as a second choice when transfemoral TAVI is not feasible due to severe comorbidities.

Citing Articles

Procedural success in transaxillary transcatheter aortic valve implantation according to type of transcatheter heart valve: results from the multicenter TAXI registry.

Schaefer A, Bhadra O, Conradi L, Westermann D, Kellner C, De Backer O Clin Res Cardiol. 2023; 113(1):48-57.

PMID: 37138103 DOI: 10.1007/s00392-023-02216-1.

References

Zhan Y, Toomey N, Ortoleva J, Kawabori M, Weintraub A, Chen F . Safety and efficacy of transaxillary transcatheter aortic valve replacement using a current-generation balloon-expandable valve. J Cardiothorac Surg. 2020; 15(1):244. PMC: 7488327. DOI: 10.1186/s13019-020-01291-z. View

Marano R, Pontone G, Agricola E, Alushi B, Bartorelli A, Cameli M . Recommendations in pre-procedural imaging assessment for TAVI intervention: SIC-SIRM position paper part 2 (CT and MR angiography, standard medical reporting, future perspectives). Radiol Med. 2022; 127(3):277-293. DOI: 10.1007/s11547-021-01434-9. View

Kappetein A, Head S, Genereux P, Piazza N, Van Mieghem N, Blackstone E . Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012; 60(15):1438-54. DOI: 10.1016/j.jacc.2012.09.001. View

Overtchouk P, Prendergast B, Modine T . Why should we extend transcatheter aortic valve implantation to low-risk patients? A comprehensive review. Arch Cardiovasc Dis. 2019; 112(5):354-362. DOI: 10.1016/j.acvd.2019.03.004. View

Schamroth Pravda N, Codner P, Vaknin Assa H, Witberg G, Assali A, Orvin K . Long Term Outcomes of Patients Treated With Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020; 141:72-78. DOI: 10.1016/j.amjcard.2020.11.007. View

Latsios G, Gerckens U, Grube E . Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients. Catheter Cardiovasc Interv. 2010; 75(7):1129-36. DOI: 10.1002/ccd.22378. View

Popma J, Deeb G, Yakubov S, Mumtaz M, Gada H, OHair D . Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1706-1715. DOI: 10.1056/NEJMoa1816885. View

Ussia G, Sarkar K, Cammalleri V, Marchei M, Muscoli S, De Vico P . Clinical results with the 31 mm CoreValveª in large aortic annuli: the importance of implantation technique. EuroIntervention. 2015; 10(9):e1-8. DOI: 10.4244/EIJV10I9A182. View

Guarracino F, Covello R, Landoni G, Baldassarri R, Stefani M, Cariello C . Anesthetic management of transcatheter aortic valve implantation with transaxillary approach. J Cardiothorac Vasc Anesth. 2010; 25(3):437-43. DOI: 10.1053/j.jvca.2010.08.015. View

10.

Modine T, Sudre A, Delhaye C, Fayad G, Lemesle G, Collet F . Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes. Ann Thorac Surg. 2012; 93(5):1489-94. DOI: 10.1016/j.athoracsur.2012.01.030. View

11.

Mack M, Leon M, Thourani V, Makkar R, Kodali S, Russo M . Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1695-1705. DOI: 10.1056/NEJMoa1814052. View

12.

Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir M . Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007; 116(11 Suppl):I240-5. DOI: 10.1161/CIRCULATIONAHA.106.677237. View

13.

Ussia G, Cammalleri V, Ascoli Marchetti A, Sarkar K, De Vico P, Muscoli S . Transcatheter aortic valve implantation through distal axillary artery: novel option for vascular access. J Cardiovasc Med (Hagerstown). 2014; 16(4):271-8. DOI: 10.2459/JCM.0000000000000063. View

14.

Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791. DOI: 10.1093/eurheartj/ehx391. View

15.

Vahanian A, Alfieri O, Andreotti F, Antunes M, Baron-Esquivias G, Baumgartner H . Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33(19):2451-96. DOI: 10.1093/eurheartj/ehs109. View

16.

Taramasso M, Maisano F, Cioni M, Denti P, Godino C, Montorfano M . Trans-apical and trans-axillary percutaneous aortic valve implantation as alternatives to the femoral route: short- and middle-term results. Eur J Cardiothorac Surg. 2011; 40(1):49-55. DOI: 10.1016/j.ejcts.2010.11.039. View

17.

Cammalleri V, Muscoli S, Versaci F, Romeo F . Periprocedural anemia management in severe aortic stenosis patients undergoing transcatheter aortic valve implantation. J Cardiol. 2019; 75(2):117-123. DOI: 10.1016/j.jjcc.2019.08.016. View

18.

Gleason T, Schindler J, Hagberg R, Deeb G, Adams D, Conte J . Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. Ann Thorac Surg. 2017; 105(2):477-483. DOI: 10.1016/j.athoracsur.2017.07.017. View

19.

Schafer U, Ho Y, Frerker C, Schewel D, Sanchez-Quintana D, Schofer J . Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach". JACC Cardiovasc Interv. 2012; 5(5):477-486. DOI: 10.1016/j.jcin.2011.11.014. View

20.

Sergi D, Acconcia M, Muscoli S, Perrone M, Cammalleri V, Di Luozzo M . Meta-analysis of the impact on early and late mortality of TAVI compared to surgical aortic valve replacement in high and low-intermediate surgical risk patients. Eur Rev Med Pharmacol Sci. 2019; 23(12):5402-5412. DOI: 10.26355/eurrev_201906_18209. View